Related Experiment Videos
[Risk stratification in non ischemic cardiomyopathy: a case report--Case 5/2010]
U Parade1, K Klingel, R Kandolf
1Abteilung für Kardiologie, Medizinische Universitätsklink Tübingen. U.Parade@klinikum-stuttgart.de <U.Parade@klinikum-stuttgart.de>
Deutsche Medizinische Wochenschrift (1946)
|June 2, 2010
Summary
Risk stratification for sudden cardiac death in non-ischaemic cardiomyopathy (NICM) is challenging. While traditional predictors are unreliable, cardiac MRI and autonomic dysfunction markers may aid risk assessment in NICM patients.
Area of Science:
- Cardiology
- Cardiac Electrophysiology
- Cardiomyopathy Research
Background:
- Non-ischaemic cardiomyopathy (NICM) presents diagnostic challenges for sudden cardiac death risk stratification.
- Established predictors for ischaemic cardiomyopathy, like heart rate turbulence and T-wave alternans, lack utility in NICM.
Observation:
- A patient with NICM and severe left ventricular dysfunction showed improvement after cardioversion and heart failure treatment.
- Cardiac MRI revealed reduced left ventricular function, mitral regurgitation, and septal late enhancement.
- Myocardial biopsies indicated remodelling, fibrosis, and mononuclear infiltrates.
Findings:
- Prognosis in NICM does not directly correlate with left ventricular function severity.
- Cardiac MRI and markers of autonomic dysfunction show potential for risk stratification in NICM.
- The role of late enhancement as a substrate for arrhythmias requires further investigation.
Implications:
- Non-invasive risk stratification may assist in borderline cases but is not mandatory for NICM.
- Close clinical monitoring under optimal medical therapy is recommended.
- Implantable cardioverter-defibrillator (ICD) implantation is superior for persistent depressed left ventricular function, though optimal timing in new NICM is undetermined.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...